The All Wales Therapeutics and Toxicology Centre (AWTTC) produce the National Prescribing Indicators (NPIs). The NPIs show how the different health boards in Wales prescribe certain medicines and highlight any differences in prescribing patterns. They are developed to promote rational prescribing of medicines in Wales and are reviewed every three years. The choice of indicators is evidence-based, and the indicators are designed to be clear and easily understood by prescribers and healthcare professionals.
The indicators allow comparison of current prescribing practice against an agreed standard of quality.
NHS Wales network users can access the majority of the data used in this report via the interactive Server for Prescribing Information and Reporting (SPIRA) dashboards.
In Focus report: 4C antimicrobials. This In Focus report includes supplementary information to that contained within the National Prescribing Indicators 2024-2025. Analysis of prescribing data to March 2025 report, to provide a more detailed picture of 4C antimicrobial (co-amoxiclav, cephalosporins, fluoroquinolones and clindamycin) prescribing across Wales. Antimicrobial stewardship is one of the NPI priority areas. The data in this report show prescribing trends for the last two years at a health board, primary care cluster and GP practice level. The percentage of practices meeting the threshold and target achievements are presented. Additionally, it includes a breakdown of 4C prescribing to explore the proportion of 4C antimicrobials prescribed. In addition, it further breaks down cephalosporin and fluoroquinolone prescribing.
⇩ In Focus report - 4C antimicrobials 1.4MB (PDF) |
(Published: April 2026)